A federal judge has cleared the way for Zantac cancer lawsuits to proceed after rejecting an effort by defendants to have all the claims against them dismissed.…
Two new FDA studies raise questions about previous claims Zantac converts into a cancer-causing chemical in the human body.…
The first Zantac bellwether trial is expected to go before juries sometime in mid-2023, according to a schedule issued by the federal judge overseeing the consolidated litigation.…
Attorneys have been appointed to leadership positions in Zantac lawsuits consolidated in California state court.…
A federal judge is prepared to hear arguments over whether Zantac lawsuits filed over NDMA contamination and cancer claims can move forward on June 3 and 4.…
Plaintiffs say Zantac manufacturers have destroyed evidence and intentionally delayed the discovery process for ongoing federal litigation in violation of court orders.…
This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased cancer risks.…
A new study links Zantac use, particularly long-term use, with an increased risk of bladder cancer.…
GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.…
A federal judge has cleared the way for direct filing in Zantac lawsuits through the use of an expedited Short Form Complaint.…
